An instrumental partnership between StemoniX and Cell Applications Inc. will enable the mass-production of one billion human induced pluripotent stem cells (HiPSC) from one lot within one week. One billion cells in one week will be high-volume, cost-effective but more importantly will accelerate the ability to understand various diseases and identify accurate and personalized treatment.
Leave a Reply